Pharmacogenomics

Papers
(The H4-Index of Pharmacogenomics is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Patient comprehension of preemptive pharmacogenomic results47
Pharmacogenomic variants affecting efficacy and safety of medicines acting on central nervous system among Sri Lankans28
How to implement pre-emptive pharmacogenetic testing in the acute hospital setting27
Whole exome sequencing identifies rare variants involved in PPIX-metabolizing pathway in anti-TB drug-induced hepatitis26
Genetics and response to treatment with metformin for type 2 diabetes21
Pharmacogenomics for Prader-Willi syndrome: caregiver interest and planned utilization19
Assessing patient understanding of pharmacogenomic test results: a qualitative study16
Genetics of tardive dyskinesia: a review of progress over the past decade15
Evidence level for pharmacogenetic testing in antidepressant treatment: a systematic review13
Pharmacogenomics in Psychiatry – the Challenge of Cytochrome P450 Enzyme Phenoconversion and Solutions to Assist Precision Dosing12
Acceptance of recommendations by a pharmacogenetics clinic11
miR-369-3p regulates the drug resistance of lung cancer cells by targeting PTPN1211
CYP2D6 genotyping in a Korean cohort: comparative analysis with Asian, Caucasian, and African populations11
A systematic review of single nucleotide polymorphisms affecting allopurinol pharmacokinetics and serum uric acid level11
Selpercatinib for RET-positive advanced pancreatic cancer detected by liquid biopsy: a case-based insight11
Characterization of CYP2C19 Pharmacogenetic Variation in African Populations and Comparison with Other Global Populations11
0.21186494827271